Keflex (Cephalexin) - Adverse Event Reports - All Cases - Drug Hypersensitivity

Adverse event in female receiving Keflex (Cephalexin)

Reported by a individual with unspecified qualification from United States on 2007-07-24

Patient: female, weighing 63.5 kg (139.7 pounds)

Adverse reactions / side effects: Dyspnoea, Drug Hypersensitivity, Urticaria, Swollen Tongue

Adverse event resulted in: life threatening event

Suspect drug(s):
Keflex
    Dosage: keflex 250mg 4 times a day by mouth within last 5 years
    Administration route: Oral
    Indication: Kidney Infection

Penicillin
    Dosage: penicillin 250mg 4 times a day by mouth within last 1 year
    Administration route: Oral
    Indication: Ear Infection

Ampicillin

Generic Steroid Dose,pack, Generic Muscle Relaxant

Adverse event in 81 year old female receiving Keflex (Cephalexin)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-06-21

Patient: 81 year old female

Adverse reactions / side effects: Staphylococcal Skin Infection, Nasopharyngitis, Furuncle, Drug Hypersensitivity

Suspect drug(s):
Revlimid
    Dosage: 10 mg, 1 in 1 d; oral, 20 mg, x28 days; oral
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2007-01-01

Revlimid
    Dosage: 10 mg, 1 in 1 d; oral, 20 mg, x28 days; oral
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2007-02-01

Keflex
    Indication: Furuncle
    Start date: 2007-05-01
    End date: 2007-05-12

Other drugs received by patient: Blood Pressure Pill (Antihypertensives) (Pill)

Adverse event in 81 year old female receiving Keflex (Cephalexin)

Reported by a health professional (non-physician/pharmacist) from United States on 2007-05-29

Patient: 81 year old female

Adverse reactions / side effects: Drug Hypersensitivity, Furuncle

Suspect drug(s):
Revlimid
    Dosage: 20 mg, x28 days, oral
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2007-02-01

Keflex
    Indication: Furuncle
    Start date: 2007-05-01
    End date: 2007-05-12

Adverse event in female receiving Keflex (Cephalexin)

Reported by a individual with unspecified qualification from United States on 2007-05-04

Patient: female

Adverse reactions / side effects: Pharyngeal Oedema, Drug Hypersensitivity, LIP Oedema

Suspect drug(s):
Keflex (Cephalexin)

Adverse event in 54 year old female receiving Keflex (Cephalexin)

Reported by a physician from United Kingdom on 2007-04-03

Patient: 54 year old female

Adverse reactions / side effects: Vomiting, Dyspnoea, Viral Infection, Nausea, Urinary Tract Infection, Hypotension, Drug Hypersensitivity, Neutrophilia, Headache, Pyrexia, Myalgia, Acute Generalised Exanthematous Pustulosis, Malaise, Arthralgia, Dysuria

Adverse event resulted in: hospitalization

Suspect drug(s):
Keflex
    Dosage: 500 mg; tid;
    Indication: Urinary Tract Infection

Azathioprine
    Dosage: 50 mg; qd
    Indication: Pemphigus

Prochlorperazine Maleate
    Indication: Nausea

Other drugs received by patient: Prednisolone; Metformin HCL

Adverse event in 58 year old female receiving Keflex (Cephalexin)

Reported by a physician from United States on 2007-01-29

Patient: 58 year old female

Adverse reactions / side effects: Oral Intake Reduced, Drug Dose Omission, Application Site Reaction, Staphylococcal Infection, Drug Hypersensitivity, Toxic Epidermal Necrolysis, Erythema Multiforme, Herpes Zoster

Suspect drug(s):
Aldara
    Dosage: 0.5 scahet, 5 in 1 weeks (s)), topical
    Administration route: Topical
    Indication: Actinic Keratosis
    Start date: 2006-01-01
    End date: 2006-01-01

Aldara
    Dosage: 0.5 scahet, 5 in 1 weeks (s)), topical
    Administration route: Topical
    Indication: Basal Cell Carcinoma
    Start date: 2006-01-01
    End date: 2006-01-01

Aldara
    Dosage: 0.5 scahet, 5 in 1 weeks (s)), topical
    Administration route: Topical
    Indication: Actinic Keratosis
    Start date: 2006-12-25
    End date: 2007-01-13

Aldara
    Dosage: 0.5 scahet, 5 in 1 weeks (s)), topical
    Administration route: Topical
    Indication: Basal Cell Carcinoma
    Start date: 2006-12-25
    End date: 2007-01-13

Altace

Hydrochlorothiazide

Zetia

Folic Acid

Aspirin

Fish OIL

Keflex